Scigen was founded in 1992 to assist the development of molecular and genetic approaches for the diagnosis and classification of human diseases. By focusing on the increasing demands to reduce exposure to toxic chemicals, implementation of new green technologies, and development of products that drastically reduce diagnostic turnaround time, we have been fortunate enough to provide our expertise globally for almost 30 years.